Online inquiry

IVTScrip™ mRNA-Human ANKRD44, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK17926MR)

This product GTTS-WK17926MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKRD44 protein. This product can be used in Lymphoid-primed multipotent progenitor cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001195144.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 91526
UniProt ID Q8N8A2
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD44, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK17926MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK16655MR IVTScrip™ mRNA-Human AMOT, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA AMOT
GTTS-WK17845MR IVTScrip™ mRNA-Human ALYREF, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ALYREF
GTTS-WK16954MR IVTScrip™ mRNA-Human AMN1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA AMN1
GTTS-WK10673MR IVTScrip™ mRNA-Human ACTR3B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ACTR3B
GTTS-WK9464MR IVTScrip™ mRNA-Human ACTL8, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ACTL8
GTTS-WK25701MR IVTScrip™ mRNA-Human ASB9, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ASB9
GTTS-WK26767MR IVTScrip™ mRNA-Human ARF5, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARF5
GTTS-WK17011MR IVTScrip™ mRNA-Human ANKRD26P1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ANKRD26P1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →